This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

8 Stocks Under $10 Loved by the Bulls

NPS Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

NPS Pharmaceuticals (NPSP) is a clinical-stage biopharmaceutical company. NPS Pharma is focused on the development of orphan products for patients with rare gastrointestinal and endocrine disorders and high unmet medical needs. This stock is trading up 7% at $7.26 in recent trading.

Today's Range: $6.77-$7.27

52-Week Range: $4.35-$10.33

Volume: 755,000

Three-Month Average Volume: 672,986

>>5 Stocks Under $10 Poised for Breakouts

From a technical perspective, NPSP is soaring here back above its 50-day moving average of $7.18 with above average volume. This move is now setting NPSP up for a much larger trend higher.

Traders should continue to look for long-biased trades as long as NPSP is trending above its 50-day with strong upside volume flows. I would consider any upside volume day that registers near or above 672,986 shares as bullish. If we continue to see that trend, then look for NPSP to re-test $7.60 and then possibly fill a previous gap back towards $8 to $8.35. This stock has some major overhead resistance at $8.35 to $8.48, so if it were to take those levels out with volume it would be very bullish in the near-term.

On the flipside, I would avoid this stock or look for short-biased trades if it fails to get into that gap, or if it drops back below its 50-day with heavy volume.

Stock quotes in this article: SQNM, MOBI, GALE, SNBC, NPSP, CSUN, AMRS, EGLE 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,385.92 +123.36 0.76%
S&P 500 1,857.53 +14.55 0.79%
NASDAQ 4,075.1360 +40.9750 1.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs